医学
鞘内
慢性疼痛
重症监护医学
药物输送
药品
选择(遗传算法)
干预(咨询)
不利影响
麻醉
物理疗法
药理学
化学
有机化学
人工智能
精神科
计算机科学
作者
Tyler Ericson,Priyanka Singla,Lynn Kohan
标识
DOI:10.1016/j.pmr.2022.01.004
摘要
Intrathecal drug delivery systems are a well-established intervention for chronic pain. The localized delivery of analgesics allows for reduced side effect profiles and pain scores in patients with chronic pain. Given their proven benefits and the development of novel intrathecal medications, intrathecal drug delivery systems are being used earlier in chronic pain management treatment pathways. Success is reliant on proper patient selection and mitigating the risks of various adverse events stemming from the implantation procedure, medications, and the device itself. This article discusses patient selection criteria, medication selection, risks, complications, supporting data, and future directions of intrathecal drug delivery systems.
科研通智能强力驱动
Strongly Powered by AbleSci AI